Missense Variant rs28362680 in BTNL2 Reduces Risk of Coronary Heart Disease
Sign Up to like & getrecommendations! Published in 2022 at "Pharmacogenomics and Personalized Medicine"
DOI: 10.2147/pgpm.s353085
Abstract: Background The pathological basis of coronary heart disease (CHD) is atherosclerosis. BTNL2 can inhibit the activation of T cells. We aimed to explore the association between BTNL2 genetic variants and CHD risk in the southern… read more here.
Keywords: rs28362680; missense; chd risk; analysis ... See more keywords